Biogen Inc. stock underperforms Tuesday when compared to competitors
The stock's fall snapped a five-day winning streak.
Biogen price target lowered to $160 from $190 at Citi
Citi analyst Geoff Meacham lowered the firm’s price target on Biogen (BIIB) to $160 from $190 and keeps a Neutral rating on the shares. Ahead ...